These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1275 related articles for article (PubMed ID: 15198963)

  • 1. Role of endothelial dysfunction in atherosclerosis.
    Davignon J; Ganz P
    Circulation; 2004 Jun; 109(23 Suppl 1):III27-32. PubMed ID: 15198963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein.
    Beckman JA; Liao JK; Hurley S; Garrett LA; Chui D; Mitra D; Creager MA
    Circ Res; 2004 Jul; 95(2):217-23. PubMed ID: 15178637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect against oxidized low-density lipoprotein-induced endothelial dysfunction.
    Li D; Mehta JL
    Endothelium; 2003; 10(1):17-21. PubMed ID: 12699073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins and endothelial dysfunction.
    Larose E; Ganz P
    Semin Vasc Med; 2004 Nov; 4(4):333-46. PubMed ID: 15861315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Change of endothelial function with aging].
    Ohnaka K; Takayanagi R
    Nihon Rinsho; 2005 Jun; 63(6):989-93. PubMed ID: 15948380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of statins on endothelium and signaling mechanisms.
    Endres M; Laufs U
    Stroke; 2004 Nov; 35(11 Suppl 1):2708-11. PubMed ID: 15375300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein-cholesterol-induced endothelial dysfunction and oxidative stress: the role of statins.
    Hermida N; Balligand JL
    Antioxid Redox Signal; 2014 Mar; 20(8):1216-37. PubMed ID: 23924077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary endothelial dysfunction: atherosclerosis.
    Shimokawa H
    J Mol Cell Cardiol; 1999 Jan; 31(1):23-37. PubMed ID: 10072713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
    Hernández-Perera O; Pérez-Sala D; Navarro-Antolín J; Sánchez-Pascuala R; Hernández G; Díaz C; Lamas S
    J Clin Invest; 1998 Jun; 101(12):2711-9. PubMed ID: 9637705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond lipid-lowering: effects of statins on endothelial nitric oxide.
    Laufs U
    Eur J Clin Pharmacol; 2003 Mar; 58(11):719-31. PubMed ID: 12634978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis-associated endothelial dysfunction.
    Schächinger V; Zeiher AM
    Z Kardiol; 2000; 89 Suppl 9():IX/70-4. PubMed ID: 11151799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size.
    Yamakuchi M; Greer JJ; Cameron SJ; Matsushita K; Morrell CN; Talbot-Fox K; Baldwin WM; Lefer DJ; Lowenstein CJ
    Circ Res; 2005 Jun; 96(11):1185-92. PubMed ID: 15905463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors.
    Urbich C; Dimmeler S
    Kidney Int; 2005 May; 67(5):1672-6. PubMed ID: 15840010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [NO and atherosclerosis].
    Ohtani K; Egashira K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():544-7. PubMed ID: 15506446
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG-CoA reductase inhibitors: Is the endothelium the main target?
    Puddu P; Puddu GM; Muscari A
    Cardiology; 2001; 95(1):9-13. PubMed ID: 11385185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial function and coronary artery disease.
    Kinlay S; Libby P; Ganz P
    Curr Opin Lipidol; 2001 Aug; 12(4):383-9. PubMed ID: 11507322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of statin use on endothelial function: from bench to clinics.
    Martínez-González J; Badimon L
    Curr Pharm Des; 2007; 13(17):1771-86. PubMed ID: 17584107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of LOX-1 by statins may relate to upregulation of eNOS.
    Mehta JL; Li DY; Chen HJ; Joseph J; Romeo F
    Biochem Biophys Res Commun; 2001 Dec; 289(4):857-61. PubMed ID: 11735125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial nitric oxide in diabetes mellitus: too much or not enough?
    Farkas K; Sármán B; Jermendy G; Somogyi A
    Diabetes Nutr Metab; 2000 Oct; 13(5):287-97. PubMed ID: 11105972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.